Spiro
Subclass of:
540 - Organic compounds -- part of the class 532-570 series
540000000 - ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1)
540001000 - HETEROCYCLIC CARBON COMPOUNDS CONTAINING A HETERO RING HAVING CHALCOGEN (I.E., OXYGEN, SULFUR, SELENIUM OR TELLURIUM) OR NITROGEN AS THE ONLY RING HETERO ATOMS
540450000 - The hetero ring contains at least eight members including nitrogen and carbon
Patent class list (only not empty are listed)
Deeper subclasses:
| Class / Patent application number | Description | Number of patent applications / Date published |
|---|---|---|
| 540466000 | Spiro | 7 |
| 20090171080 | Intermediate and Process of Preparation of Ecteinascidin Such as Ecteinascidines-583,597 Using Such Intermediate - The present invention concerns an intermediate of the following formula (I) in which R | 07-02-2009 |
| 20100216987 | SYNTHESIS OF NATURALLY OCCURING ECTEINASCIDINS AND RELATED COMPOUNDS - Ecteinascidin compounds with a quinone ring for ring E are active as anti-cancer agents. Related processes and compounds are provided. | 08-26-2010 |
| 20110251384 | CYCLIC CARBODIIMIDE COMPOUNDS - A cyclic carbodiimide compound which is useful as an end-sealing agent for polymer compounds. The cyclic carbodiimide compound is represented by the following formula (i): | 10-13-2011 |
| 20130066067 | Synthetic Process for the Manufacture of Ecteinascidin Compounds - This invention relates to compounds of formula II: wherein R | 03-14-2013 |
| 20130079510 | CYCLIC CARBODIIMIDE COMPOUND - Disclosed is a cyclic carbodiimide compound useful as an end-capping agent for polymer compounds. The cyclic carbodiimide compound is represented by the following formula (i): | 03-28-2013 |
| 20130085274 | PROCESS FOR THE PRODUCTION OF A CARBODIIMIDE - A process for the production of a carbodiimide, comprising the steps of: | 04-04-2013 |
| 20150307455 | HETEROCYCLIC COMPOUNDS - Described herein are methods for synthesizing heterocyclic, 8-membered ring structures. The methods may allow for preparation of highly substituted 8-membered rings. Also disclosed are heterocyclic, 8-membered ring compounds and pharmaceutical compositions comprising the compounds. | 10-29-2015 |